Submission Details
| 510(k) Number | K213349 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 08, 2021 |
| Decision Date | June 23, 2022 |
| Days to Decision | 258 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K213349 is an FDA 510(k) clearance for the Catalyst R1 Reverse Shoulder System, a Shoulder Prosthesis, Reverse Configuration (Class II — Special Controls, product code PHX), submitted by Catalyst Orthoscience, Inc. (Naples, US). The FDA issued a Cleared decision on June 23, 2022, 258 days after receiving the submission on October 8, 2021. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3660.
| 510(k) Number | K213349 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 08, 2021 |
| Decision Date | June 23, 2022 |
| Days to Decision | 258 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | PHX — Shoulder Prosthesis, Reverse Configuration |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3660 |
| Definition | Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint. |